Economics and management in the biopharmaceutical industry in the USA : evolution and strategic change / Rachel Kim.
"From a managerial perspective, the biopharmaceutical industry represents a competitive, fast-changing, intellectually-powered, innovation-driven sector. Many management scholars have studied this discontinuous era to make sense of strategic behavior and the cognition of firms and top managers....
Saved in:
| Online Access: |
Full Text (via Taylor & Francis) |
|---|---|
| Main Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
London ; New York :
Routledge,
2019.
|
| Series: | Routledge studies in the economics of business and industry ;
4. |
| Subjects: |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | b11650823 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 190329s2019 enk ob 001 0 eng | ||
| 005 | 20241118152158.8 | ||
| 010 | |a 2019015328 | ||
| 019 | |a 1076873345 |a 1077988465 | ||
| 020 | |a 9781351012713 |q (eBook) | ||
| 020 | |a 1351012711 | ||
| 020 | |z 9781138500273 |q (hardback : alk. paper) | ||
| 020 | |a 9781351012690 |q (electronic bk.) | ||
| 020 | |a 135101269X |q (electronic bk.) | ||
| 020 | |z 1138500275 |q (hardback) | ||
| 029 | 1 | |a AU@ |b 000065191024 | |
| 035 | |a (OCoLC)tfe1091237715 | ||
| 035 | |a (OCoLC)1091237715 |z (OCoLC)1076873345 |z (OCoLC)1077988465 | ||
| 037 | |a tfe9781351012713 | ||
| 040 | |a DLC |b eng |e rda |c DLC |d OCLCF |d DLC |d OCLCO |d N$T |d YDX |d OSU |d OCLCO |d OCLCQ |d SFB |d OCLCO |d OCLCL | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 049 | |a GWRE | ||
| 050 | 0 | 0 | |a HD9666 |
| 100 | 1 | |a Kim, Rachel, |d 1970- |e author. |0 http://id.loc.gov/authorities/names/no2018138579 |1 http://isni.org/isni/0000000499781811 | |
| 245 | 1 | 0 | |a Economics and management in the biopharmaceutical industry in the USA : |b evolution and strategic change / |c Rachel Kim. |
| 264 | 1 | |a London ; |a New York : |b Routledge, |c 2019. | |
| 300 | |a 1 online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a volume |b nc |2 rdacarrier | ||
| 490 | 1 | |a Routledge studies in the economics of business and industry ; |v 4 | |
| 520 | |a "From a managerial perspective, the biopharmaceutical industry represents a competitive, fast-changing, intellectually-powered, innovation-driven sector. Many management scholars have studied this discontinuous era to make sense of strategic behavior and the cognition of firms and top managers. A past look at the biopharmaceutical industry provides answers to questions that most managers have. For example, what options do you have and what actions do you take when new firms enter your industry? In the 1970s, new biotechnology firms, funded by venture capitalists, appeared in the pharmaceutical industry with new knowledge. Successful pharmaceutical firms decided to collaborate with the new entrants and forge relationships to develop and create new, biotechnology engineered drugs. Thus, the addition of new biotechnology firms ushered in a new business model based on strategic alliances. Strategic alliances have now become an industrial norm called open innovation. The author looks at the historical path of the biopharmaceutical industry, particularly in the United States. While the pharmaceutical industry's main contributions to society are substantial, there are pressing challenges the industry must face, such as an increase in infectious disease outbreaks or the global aging population, which require new types of care, additionally, mental health care and prescription painkiller addiction are persistent issues with economic repercussions to both federal and local governments. This book presents a holistic view of the biopharmaceutical industry, putting it in a historical context. It will best serve those eager to learn about this dynamic, fast-evolving industry"-- |c Provided by publisher. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Overview of strategic management and corporate practice in the U.S. -- Introduction -- In early days of pharmaceutical industry worldwide -- The birth of biotechnology -- Emergence of biotechnology firms in 1970s & 1990s -- New biotechnology firms emergence from pharmaceutical management perspective -- U.S. regulations on biopharmaceutical industry and their impact -- Law & strategies: how biopharma's strategies adapted in response to U.S. law changes -- Opportunistic business models is the generic drug market -- Low productivity of drug companies -- Payers, purchasers, & promotions -- Innovation capabilities -- Immuno-cancer therapy -- Biopharmaceutical industry in the future. | |
| 588 | |a Description based on print version record; title from PDF title page, viewed (06/10/2020). | ||
| 650 | 0 | |a Pharmaceutical biotechnology industry |z United States |x History. | |
| 650 | 0 | |a Pharmaceutical biotechnology |z United States |x History. | |
| 650 | 7 | |a Pharmaceutical biotechnology. |2 fast | |
| 650 | 7 | |a Pharmaceutical biotechnology industry. |2 fast | |
| 651 | 7 | |a United States. |2 fast | |
| 655 | 7 | |a History. |2 fast | |
| 758 | |i has work: |a Economics and management in the biopharmaceutical industry in the USA (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGKd9tFkWXB3GVjqWQFWcK |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Kim, Rachel, 1970- author. |t Economics and management in the pharmaceutical industry in the USA |d Abingdon, Oxon ; New York, NY : Routledge, 2019 |z 9781138500273 |w (DLC) 2018042746 |
| 856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=https://www.taylorfrancis.com/books/9781351012713 |z Full Text (via Taylor & Francis) |
| 830 | 0 | |a Routledge studies in the economics of business and industry ; |v 4. |0 http://id.loc.gov/authorities/names/no2017107234 | |
| 915 | |a - | ||
| 944 | |a MARS - RDA ENRICHED | ||
| 956 | |a Taylor & Francis Ebooks | ||
| 956 | |b Taylor & Francis All eBooks | ||
| 956 | |a Quesnalia testing - EUI | ||
| 994 | |a 92 |b COD | ||
| 998 | |b Added to collection informaworld.tandfebooks | ||
| 999 | f | f | |i 3b2243e8-77ee-54b4-b6f8-7913d2199805 |s 3ef5fe08-da9a-5bd0-84fa-0a0d8a666678 |
| 952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e HD9666 |h Library of Congress classification |i web |n 1 |